Trials / Unknown
UnknownNCT01938534
Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 440 (estimated)
- Sponsor
- Ajou University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Prospective study : Helicobacter pylori eradication therapy in accordance with past antibiotics use.
Detailed description
Antibiotics resistant is serious problem in helicobacter pylori eradication. Clarithromycin is very important antibiotics in eradication. But clarithromycin resistance is increased. Major cause of clarithromycin resistance is past consumption of macrolide. Thus the investigators propose eradication of macrolide used group bismuth contained four drugs therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Helicobacter pylori eradication |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-12-01
- First posted
- 2013-09-10
- Last updated
- 2014-01-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01938534. Inclusion in this directory is not an endorsement.